Health Condition 1: N978- Female infertility of other origin Health Condition 2: N971- Female infertility of tubal origin Health Condition 3: N979- Female infertility, unspecified
Conditions
Interventions
Intervention1: Dual Trigger:
Injection Leuprolide 1 mg given subcutaneously along with injection Recombinant Human Chorionic Gonadotropin (r-hCG) 250mcg given subcutaneously, single dose each.
Cont
Sponsors
Dr Aryan Kashyap
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients willing to participate 2 Age - 21 to 38 years (both included) 3 Tubal factor infertility 4 Male factor infertility 5 Unexplained infertility 6 Normal ovarian reserve â?? A baseline Antral follicle count between 5-15(both of which are included)
Exclusion criteria
Exclusion criteria: 1 Patients with Polycystic Ovarian syndrome 2 Patients with Endocrine disorders â?? Diabetes Mellitus, uncorrected hypothyroidism, Hyperprolactinemia, congenital adrenal hyperplasia • Patients with Thin endometrium ( • Previous History of uterine surgeries, adhesiolysis, myomectomy and adenomyosis • Poor Ovarian reserve (AFC
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Number of Metaphase II oocytes retrieved 2.Number of good quality embryos Timepoint: 1. At time of Oocyte retreival 2. At time of Embryo transfer | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Determination of Luteinizing hormone levels twelve hours post trigger 2. Implantation rates in both the group 3. Number of embryos frozen Timepoint: 1.12 hours after trigger administration 2. 14 days after Embryo transfer 3. AT time of embryo transfer | — |
Countries
India
Contacts
Public ContactDr Aryan Kashyap
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed